<bill session="118" type="s" number="4419" updated="2025-05-27T14:15:52Z">
  <state datetime="2024-09-18">REPORTED</state>
  <status>
    <unknown datetime="2024-09-18"/>
  </status>
  <introduced datetime="2024-05-23"/>
  <titles>
    <title type="short" as="introduced">DETECT Fentanyl and Xylazine Act of 2024</title>
    <title type="short" as="introduced">Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024</title>
    <title type="short" as="reported to senate">DETECT Fentanyl and Xylazine Act of 2024</title>
    <title type="short" as="reported to senate">Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024</title>
    <title type="display">DETECT Fentanyl and Xylazine Act of 2024</title>
    <title type="official" as="introduced">A bill to require the Science and Technology Directorate in the Department of Homeland Security to develop greater capacity to detect, identify, and disrupt illicit substances in very low concentrations.</title>
  </titles>
  <sponsor bioguide_id="C001056"/>
  <cosponsors>
    <cosponsor bioguide_id="L000575" joined="2024-05-23"/>
    <cosponsor bioguide_id="M000934" joined="2024-09-16"/>
    <cosponsor bioguide_id="O000174" joined="2024-05-23"/>
    <cosponsor bioguide_id="R000608" joined="2024-07-23"/>
    <cosponsor bioguide_id="S001191" joined="2024-05-23"/>
    <cosponsor bioguide_id="W000790" joined="2024-11-20"/>
  </cosponsors>
  <actions>
    <action datetime="2024-05-23">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2024-05-23" state="REFERRED">
      <text>Read twice and referred to the Committee on Homeland Security and Governmental Affairs.</text>
    </action>
    <action datetime="2024-09-18" state="REPORTED">
      <text>Committee on Homeland Security and Governmental Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2024-12-02">
      <text>Committee on Homeland Security and Governmental Affairs. Reported by Senator Peters with an amendment in the nature of a substitute and an amendment to the title. With written report No. 118-253.</text>
    </action>
    <calendar datetime="2024-12-02" calendar="Senate Legislative" under="General Orders" number="654">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 654.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSGA" name="Senate Homeland Security and Governmental Affairs" subcommittee="" activity="Reported By, Markup By, Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="8663" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Science, technology, communications"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Computers and information technology"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Libraries and archives"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2024-09-11T21:12:54Z" status="Introduced in Senate">Detection Equipment and Technology Evaluation to Counter the Threat of Fentanyl and Xylazine Act of 2024 or the DETECT Fentanyl and Xylazine Act of 2024

This bill provides statutory authority for the Department of Homeland Security's Science and Technology Directorate to take certain actions to support the detection of drugs such as fentanyl and xylazine.

Specifically, the bill provides statutory authority for the directorate's research and development efforts to improve drug detection equipment and reference libraries for law enforcement agencies, including with respect to portable equipment, equipment&#160;that can analyze complex samples, and technology that uses artificial intelligence or other techniques to detect new substances. The bill additionally requires the directorate to follow certain standards and rely on certain information from&#160;the National Institute of Standards and Technology and the Drug Enforcement Administration, respectively, regarding these efforts.</summary>
  <committee-reports>
    <report>S. Rept. 118-253</report>
  </committee-reports>
</bill>
